You are here

  • Home
  • Archive
  • Volume 76, Issue 2
  • Response to: ‘Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?’ by Nocturne et al

Article metrics

Article menu

Download PDFPDF

Electronic pages
Correspondence response
Response to: ‘Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?’ by Nocturne et al
Free

 

Online download statistics by month:

Online download statistics by month: December 2016 to March 2024

AbstractFullPdf
Dec 201622914850
Jan 201746581129
Feb 2017844948
Mar 201724533
Apr 201736324
May 201723612
Jun 201783313
Jul 201758517
Aug 2017444410
Sep 201727274
Oct 201718181
Nov 201721218
Dec 201721215
Jan 2018303014
Feb 201830268
Mar 201822144
Apr 201830305
May 2018404210
Jun 201827276
Jul 201819193
Aug 201816141
Sep 201816167
Oct 2018770
Nov 201811110
Dec 201813111
Jan 2019662
Feb 2019884
Mar 201917178
Apr 201917104
May 20191194
Jun 2019885
Jul 201913125
Aug 20191097
Sep 201910102
Oct 2019883
Nov 2019772
Dec 201916168
Jan 2020996
Feb 2020880
Mar 2020443
Apr 20201181
May 202013123
Jun 202011117
Jul 202011116
Aug 2020443
Sep 202019183
Oct 2020771
Nov 2020663
Dec 2020885
Jan 2021875
Feb 2021665
Mar 202110106
Apr 2021664
May 2021443
Jun 2021652
Jul 202116145
Aug 2021546
Sep 2021151410
Oct 20215412
Nov 20217614
Dec 202119187
Jan 202219184
Feb 2022441
Mar 202215135
Apr 202219193
May 2022282815
Jun 202231318
Jul 202210105
Aug 202236352
Sep 2022272514
Oct 2022262510
Nov 202212121
Dec 202217163
Jan 20231295
Feb 202338371
Mar 2023540
Apr 2023332
May 2023336
Jun 2023111
Jul 2023229
Aug 2023208
Sep 2023331
Oct 2023983
Nov 20231181
Dec 202316132
Jan 2024553
Feb 2024543
Mar 20247723
Total19581551716